Besides ERBB2, other potentially actionable genes that have been found to be often amplified in breast cancer, including TNBC, are NOTCH1/2/3, MYC, FGFR1/2, and EGFR, with EGFR amplification associated with poor patients outcome [86,87]. The gene discussed is EGFR; the disease is breast carcinoma.